• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Acorda Therapeutics Inc

+ Add to Watchlist

ACOR:US

29.5500 USD 0.8300 2.73%

As of 15:09:55 ET on 07/24/2014.

Snapshot for Acorda Therapeutics Inc (ACOR)

Open: 30.4400 Day's Range: 29.5400 - 30.6700 Volume: 307,807
Previous Close: 30.3800 52wk Range: 27.5100 - 39.9450 1-Yr Rtn: -19.90%

Stock Chart for ACOR

No chart data available.
  • ACOR:US 29.5600
  • 1D
  • 1M
  • 1Y
30.3800
Interactive ACOR Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ACOR

Current P/E Ratio (ttm) 66.2670
Estimated P/E(12/2014) 31.5806
Relative P/E vs. SPX 3.5792
Earnings Per Share (USD) (ttm) 0.4523
Est. EPS (USD) (12/2014) 0.9490
Est. PEG Ratio 0.5589
Market Cap (M USD) 1,250.74
Shares Outstanding (M) 41.73
30 Day Average Volume 702,482
Price/Book (mrq) 2.6946
Price/Sale (ttm) 3.4693
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 07/31/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ACOR

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for ACOR

Acorda Therapeutics Inc. is a biotechnology company that is developing therapies for spinal cord injury and related neurological conditions, including multiple sclerosis. Additionally, Acorda is developing multiple approaches to regeneration and repair of the spinal cord and brain.

Ron CohenPresident/CEO/FounderMichael W RogersChief Financial Officer
Andrew HindmanChief Business Development OfcrEnrique J CarrazanaChief Medical Officer
More Company Profile & Key Executives for ACOR

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil